SRIVICHAIVEJVIVAT PUBLIC COMPANY LIMITEDSET: VIH🇹🇭 TH

Board Performance · 2025

Compliance Monitoring — Overview

Monitoring of Compliance with Other CG Policies & Guidelines

The Company places great importance on good corporate governance and has continuously monitored the implementation of policies and best practices over the past year. The summary of key activities is as follows:


  1. Compliance with Good Corporate Governance Principles

  • The Company adheres to the good corporate governance principles set by the Stock Exchange of Thailand (SET) and has fully complied with the Corporate Governance Code (CG Code) issued by SET. Various governance practices have been applied to align with the Company’s business structure.

  • Corporate governance practices have been established in the form of a Code of Conduct, serving as a guideline for directors, executives, and employees at all levels.

  • The Company ensures accurate, complete, and timely disclosure of information in accordance with good corporate governance principles and regulatory requirements. Financial reports, such as annual financial statements and the 56-1 One Report, have been disclosed, along with active participation in events such as Opportunity Day and investor meetings.


  1. Risk Management and Internal Control

  • The Risk Management Committee regularly reviews and assesses the Company's risks to ensure effective and timely risk management.

  • A comprehensive risk management plan has been developed, covering all aspects of the business, including strategic, operational, financial, regulatory, and technological risks. Risk management measures are continuously monitored and updated to align with business changes.


  1. Business Ethics and Human Rights Practices

  • The Company promotes clear business ethics policies, requiring employees at all levels to comply. Training on business ethics is provided to new employees to foster awareness and understanding of ethical conduct.

  • Internal communication channels, including the Company’s website, intranet system, and internal email, are used to disseminate ethical guidelines and best practices. Additionally, employees and stakeholders are provided with secure channels to report violations of business ethics and human rights, as follows:


Reporting Channels: Email: VIH.whistleblower@vichaivej.com or Postal Mail:

Head of Internal Audit

Srivichai Vejvivat Public Company Limited

74/5 Moo 4, Phetkasem Road, Krathum Baen, Samut Sakhon 74130


In cases where a complaint involves the Chief Executive Officer,

Reports should be submitted directly to the Chairman of the Audit Committee

Email: audit.chairman@vichaivej.com or Postal Mail: Chairman of the Audit Committee

Srivichai Vejvivat Public Company Limited

74/5 Moo 4, Phetkasem Road, Krathum Baen, Samut Sakhon 74130


Throughout the past year, the Company has fully complied with corporate governance policies and best practices with transparency and efficiency. No complaints related to governance violations or unethical business conduct were reported. The Company remains committed to continuously enhancing corporate governance practices to align with international standards.

Prevention of Conflicts of Interest

Has the Company Acted to Prevent Conflicts of Interest?

Yes

Operations in the Past Year

The company has established guidelines to prevent conflicts of interest between the company, its subsidiaries, affiliates, directors, executives, and related parties to ensure transparent and fair operations, while prioritizing the interests of the company and its shareholders. Therefore, the company has set forth the following practices regarding conflicts of interest:


  • Directors, executives, and employees of the company shall not seek personal benefits or engage in any form of personal or related business with the company, either directly or indirectly. They shall not use or disclose any confidential, non-public information for personal gain or share such information with external parties.

  • Transactions between the company and its directors, executives, or related parties, or transactions that involve themselves or their related parties, should be avoided. If such transactions occur, they must be reviewed and approved in accordance with the established criteria.

  • The board of directors and senior executives of the company and all subsidiaries are required to comply with the regulations set forth by the Stock Exchange of Thailand and the Securities and Exchange Commission regarding the disclosure of related party transactions and conflicts of interest. Any transactions that could impact the company must be approved by the company's board of directors or the shareholders' meeting.

  • Directors, executives, and employees of the company and all subsidiaries are obligated to report any misconduct they witness involving their colleagues, superiors, executives, or directors. Failure to report such misconduct will be considered a violation of the company's rules, regulations, and policies.

The company has an internal audit department responsible for overseeing and ensuring the accuracy of related party transactions, business processes, and approval procedures in accordance with good governance practices, the company’s policies, and applicable laws and regulations. The internal audit department conducts systematic and independent audits, emphasizing transparency, accuracy, and efficient management.


In 2025, based on the results of audits and assessments, it was found that the Company’s directors, executives, employees, and personnel strictly complied with the policies, guidelines, and the Company’s code of conduct. During the reporting year, no cases of misconduct or behaviors constituting conflicts of interest that could adversely affect the Company or its stakeholders were identified (zero cases).

In addition, the Internal Audit function continuously monitored and evaluated the Company’s transactional processes to ensure that all procedures were conducted in accordance with established policies, standards, and applicable laws. This ongoing oversight aims to enhance the effectiveness of internal controls and to prevent and mitigate risks arising from potential conflicts of interest, thereby supporting sound corporate governance and sustainable business operations.

Number of Conflict-of-Interest Cases

MetricCurrent YearPrevious YearTwo Years Ago
Total number of cases or issues related to conflicts of interest (cases)000

Prevention of the Use of Inside Information

Has the Company Acted to Prevent the Use of Inside Information?

Yes

Operations in the Past Year

The company places great importance on preventing insider trading for personal gain or for the benefit of external parties, which could compromise the company’s transparency and credibility and harm shareholders and stakeholders. Therefore, the company has implemented measures and guidelines to control and prevent the misuse of inside information as follows:

  • The company has established a policy to prevent insider trading, requiring directors, executives, and employees to comply. It is prohibited for directors, executives, and employees to use non-public information for trading the company's securities or to advise others to trade such securities. Individuals responsible for handling inside information must maintain the confidentiality of such information and not disclose it to outsiders without authorization.

  • The company implements access control measures to internal information, ensuring that only authorized individuals can access confidential data. The company has a system to control access to documents and electronic information to prevent the leakage of critical information, including the use of passwords and data encryption.

  • The company provides training for directors and executives regarding their duty to report securities holdings of themselves, their spouses, and underage children to the Securities and Exchange Commission (SEC) in accordance with Section 59 and penalties under Section 275 of the Securities and Exchange Act of 1992 (as amended).

  • Directors and executives, including their spouses and underage children, are required to prepare and disclose their securities holdings and changes in holdings to the SEC, in accordance with Section 59 and penalties under Section 275 of the Securities and Exchange Act of 1992 (as amended).

  • The Company’s directors and executives, including their spouses and minor children, are required to prepare and disclose a report on their securities holdings and a report on changes in their securities holdings to the Securities and Exchange Commission under Section 59 and the penalty provisions under Section 275 of the Securities and Exchange Act B.E. 2535 (including amendments) and submit a copy of this report to the Company Secretary on the same day that the report is submitted to the Securities and Exchange Commission.

  • The Company requires directors, executives, employees, and staff who are in possession of inside information that may affect the Company’s share price to refrain from trading the Company’s securities during the period designated as the “Blackout Period.” The Blackout Period is defined as a period of at least 30 days prior to the disclosure of financial statements or other material information that may impact the share price. Trading may resume no earlier than 24 hours after such information has been publicly disclosed. During this period, such persons are strictly prohibited from disclosing the information to any third party prior to its official disclosure to the Stock Exchange. Any violation of this policy constitutes a disciplinary offense and may result in penalties ranging from a formal warning to termination of employment.

  • The Company’s directors, executives, and employees are required not to use confidential and/or inside information to make transactions, buy, sell, transfer the Company’s securities, or to persuade other persons to buy, sell, or offer to buy or sell the Company’s securities for the benefit or to seek benefits from any person or group of persons.


Support from the Company Secretary

In the conduct of the Company’s business, the Company Secretary plays a key role in supporting good corporate governance practices, particularly in relation to the prevention of insider trading. The Company Secretary is responsible for notifying directors, executives, and relevant employees who have access to material non-public information that may affect the Company’s share price of the Company’s prescribed trading blackout periods (Blackout Period) to prevent the misuse of inside information. The Company Secretary provides advance notice of the Blackout Period of not less than 30 days to ensure that relevant persons are able to comply with the Company’s policies and guidelines appropriately.

The Blackout Period is defined as a period during which directors, executives, and relevant persons are prohibited from trading the Company’s securities for at least 30 days prior to the disclosure of financial statements or other material information that may affect the share price. Trading may resume no earlier than 24 hours after such information has been publicly disclosed. The Company may also impose additional blackout periods on a case-by-case basis, as deemed appropriate.

In addition, directors and senior executives are required to notify the Company Secretary at least 24 hours in advance of any intended trading of the Company’s securities, in order to ensure compliance with the Company’s corporate governance policies and practices.

Even in cases where no formal Blackout Period has been announced prior to the disclosure of quarterly or annual financial results, any employee who is aware—directly or indirectly—of the Company’s financial performance or other material non-public information is deemed to be in possession of inside information and must refrain from trading the Company’s securities until such information has been publicly disclosed.

In 2025, the Company strictly enforced its insider trading prevention measures. There were no instances of non-compliance by directors, executives, employees, or related persons, and no trading of the Company’s securities occurred during the prescribed blackout periods (0 cases).

Number of Inside-Information Cases

MetricCurrent YearPrevious YearTwo Years Ago
Total number of cases or issues related to the use of inside information to seek benefits (cases)000

Anti-Corruption

Introduction

The company is committed to conducting its business with transparency and ethics, adhering to the principles of good corporate governance and strictly complying with laws related to the prevention and suppression of fraud and corruption. This includes the prohibition of giving or receiving bribes from both government officials and private entities. To ensure efficient operations free from corruption risks, the company has established a clear organizational structure that systematically defines roles, responsibilities, workflows, and reporting lines within each department. This structure minimizes opportunities for corruption and enhances transparency in operations. Additionally, the company has set operational guidelines for directors, executives, and employees at all levels to ensure compliance with corporate governance principles and to prevent involvement in fraud or corruption. These guidelines cover aspects such as refraining from accepting gifts or benefits that may compromise impartiality, refusing to engage in unethical transactions, and encouraging employees to report any misconduct through designated channels.


For more details, please refer to the Anti-Corruption Policy Full Version

Has the Company Acted on Anti-Corruption?

Yes

Operations in the Past Year


Anti-Corruption Policy

The Board of Directors places great importance on good corporate governance, transparency, and ethical business conduct. The Company regularly reviews its Anti-Corruption Policy to ensure that it remains appropriate, up-to-date, and aligned with applicable laws, regulatory requirements, and relevant international standards.

Following careful consideration, the Board of Directors approved the revision of the Anti-Corruption Policy on 18 December 2025. The management and the Company Secretary have been assigned to oversee its implementation, monitor compliance, and report the results to the Board on a regular basis to ensure effectiveness and accountability.

The Company has communicated and disseminated this policy to directors, executives, and employees at all levels, including those of its subsidiaries, through various channels such as internal meetings, electronic communications, internal announcements, and the Code of Business Conduct. This ensures that all personnel understand and can properly comply with the prescribed guidelines. In addition, the Company provides training and orientation programs on anti-corruption practices to promote transparency, fairness, and adherence to good corporate governance principles, as well as to cultivate a corporate culture that does not tolerate any form of corruption.

The Company has established secure and confidential whistleblowing channels to enable stakeholders to report information or complaints regarding suspected misconduct. A fair and transparent investigation process is in place, along with appropriate protection measures for whistleblowers.


Participation in the Collective Action Against Corruption (CAC)

The Company has participated in the Thai Private Sector Collective Action Against Corruption (CAC). It signed the declaration of intent to join the initiative on 23 December 2016, demonstrating its commitment to conducting business with transparency and opposing all forms of corruption.

The Company has received its second renewal of CAC certification for the period from 31 March 2025 to 31 March 2028. This reflects the Company’s continued adherence to good corporate governance standards and ethical business practices.

Anti-Corruption Practices and Measures

The Company has established a comprehensive framework of anti-corruption policies and measures, covering risk assessment, internal control measures, communication and training, compliance oversight, and continuous monitoring and evaluation. This framework ensures that business operations are conducted with transparency, are auditable, and foster confidence among all stakeholders, in alignment with the principles of good corporate governance (CG Code) and ESG practices.

1. Communication and Awareness Building
The Company ensures that its Anti-Corruption Policy is widely communicated to employees at all levels through various channels, including internal briefings, the Company’s website, intranet systems, internal announcements, and the Code of Business Conduct. In addition, training sessions and orientation programs for new employees are provided to instill understanding and raise awareness of the importance of transparency and integrity from the outset of employment.

2. Whistleblowing Channels and Whistleblower Protection
The Company has established whistleblowing channels for employees and external parties to report suspected misconduct or violations of policies. Appropriate whistleblower protection measures are in place to prevent retaliation or adverse consequences arising from such reports. The complaint review and investigation process is conducted in a fair, transparent, and verifiable manner.

3. Policies, Procedures, and Internal Control System
The Company has established and enforced clear policies and procedures to mitigate corruption risks, including procurement procedures to promote transparency, policies governing cash receipts and disbursements, and financial control processes in accordance with established standards. The Company also implements a Delegation of Authority framework to clearly define roles and responsibilities, as well as guidelines on the giving and receiving of gifts or other benefits to prevent bribery risks.

4. Governance, Monitoring, and Evaluation
The Company assigns relevant committees to systematically oversee and monitor corruption risks, as follows:

  • The Corporate Governance and Sustainability Committee is responsible for overseeing compliance with policies and risk control measures

  • The Risk Management Committee is responsible for identifying and assessing corruption risks and establishing appropriate preventive measures

  • The Audit Committee is responsible for reviewing the internal control system and providing recommendations for continuous improvement

The performance of anti-corruption initiatives is regularly reported to the Board of Directors to ensure that such measures are effective and capable of appropriately mitigating risks.

In 2025, the Company did not receive any whistleblowing reports, issues, or complaints related to corruption, bribery, or violations of corporate governance policies (0 cases), from both internal and external sources.

The Company continues to maintain preventive and monitoring measures against corruption, focusing on policy communication, fostering a transparent and ethical corporate culture, and promoting the use of secure and confidential whistleblowing channels. This ensures timely investigation and remediation should any incidents of potential misconduct or ethical violations arise. These efforts reflect the Company’s commitment to enhancing governance standards, effectively managing corruption risks, and building sustainable confidence among all stakeholders.

Form of Anti-Corruption Operations

Operation
Review of appropriateness in anti-corruption
The participation in anti-corruption projects
Assessment and identification of corruption risk
Communication and training for employees on anti-corruption policy and guidelines
The monitoring of the evaluation of compliance with the anti- corruption policy
Review of the completeness and adequacy of the process by the Audit Committee or auditor

Number of Corruption Cases

MetricCurrent YearPrevious YearTwo Years Ago
Total number of cases or issues related to corruption (cases)000

Whistleblowing

Has the Company Implemented Whistleblowing Procedures?

Yes

Operations in the Past Year

The Company encourages employees and stakeholders to jointly monitor and report any actions that violate the principles of good governance, ethics, the Company’s rules and regulations, including illegal actions or violations of the rights of stakeholders, which may affect or cause damage to the Company. In this regard, whistleblowers can submit a complaint with relevant documents or evidence, indicating the name and surname of the whistleblower (if the name and surname are not specified, the matter may not be considered). This is for the convenience of contacting and requesting additional information. Complaints can be filed through the following channels:


To Chairman of the Audit Committee or Independent Director,

Internal Audit Department,

Srivichai Vejvivat Co., Ltd. (Public Company Limited),

74/5 Moo 4, Phetkasem Road, Om Noi Subdistrict,

Krathum Baen District, Samut Sakhon Province 74130,

Tel. 02 441 7899 ext. 4526,

E-mail: audit.vih@gmail.com


Consideration Procedure

When the Chairman of the Audit Committee or Independent Director receives a complaint, they will conduct a preliminary consideration of whether there is any basis for wrongdoing. If sufficient basis is found, the matter will be presented to the Audit Committee for consideration. and notify the initial consideration results to the informant within 14 days from the date of receipt of the complaint. The Company will then proceed with appropriate procedures, including reporting to the Company's Board of Directors for consideration of corrective action and appropriate action. The Company will protect the rights of the informant as confidential to prevent any impacts that may arise from reporting information.

Number of Whistleblowing Cases

MetricCurrent YearPrevious YearTwo Years Ago
Total number of cases or issues received through whistleblowing channels (cases)000

Selection of Directors & Chief Executives

Selection, Development & Evaluation — Introduction

The Board of Directors plays a vital role in corporate governance to ensure the company's best interests. This responsibility is established in the corporate governance principles under the section on the Board’s responsibilities. The Board structure must be diverse in terms of skills, professional expertise, specialized competencies, and gender. Additionally, any essential skills lacking within the Board should be identified. To facilitate this, the company may consider engaging advisory firms or utilizing director databases. Once the Board identifies suitable candidates, their names will be proposed to the shareholders for approval and appointment as directors.


The Board of Directors is appointed by the shareholders through a transparent process to oversee the company’s strategic direction. The company places great importance on the Board’s role and responsibilities, which include guiding the company’s operations, overseeing management’s performance, and ensuring accountability to both the company and its shareholders. The key principles for the nomination and appointment of directors and senior executives are as follows:


Structure of the Board of Directors

The Board of Directors shall consist of at least five (5) directors, as stipulated in the Company’s Articles of Association, Chapter 4, Article 14. All directors must possess the qualifications required and must not have any prohibited characteristics as prescribed under the Public Limited Companies Act. The Board shall comprise individuals with knowledge, competence, and diverse skills. In addition, at least one-third of the total number of directors, and no fewer than three persons, must be independent directors in order to ensure that there are sufficient independent directors to effectively oversee and balance the performance of the Board and the management’s operations.

At present, the Company has appointed independent directors in full compliance with the requirements prescribed by law.

Board Structure and Diversity

At present, the Company’s Board of Directors comprises a total of 12 directors, consisting of:

  • 5 executive directors, representing 41.67% of the total number of directors; and

  • 7 non-executive directors, representing 58.33% of the total number of directors, of which

    • 4 are independent directors, accounting for 33.33% of the total number of directors.

In addition, the Company has 3 female directors out of a total of 12 directors, representing 25.00% of the Board. The presence of female directors contributes to a diversity of perspectives, more balanced deliberation, and enhanced decision-making by incorporating varied experiences and viewpoints in the Board’s discussions.

Furthermore, should there be an expansion of the Board of Directors in the future, the Company is committed to promoting gender diversity by ensuring equal opportunity for all qualified candidates, regardless of gender identity. We also support the appropriate adjustment of the existing Board’s gender composition to enhance collective efficiency and the overall quality of the Board’s performance."

The Board of Directors has assigned the Nomination and Remuneration Committee to be responsible for establishing criteria, identifying, and selecting directors and top executives in the event of a vacancy, with due consideration given to qualifications, experience, independence, and diversity. This process is designed to align with the principles of good corporate governance.

Furthermore, the Board has established a policy regarding the number of directorships that a Board member may hold in listed companies. This policy ensures that the company benefits from directors who can dedicate sufficient time to their duties effectively. Accordingly, each director should not serve as a director in more than five (5) listed companies.

Directors & Chief Executives — Introduction

The company conducts the recruitment of directors and top executives with careful consideration of the qualifications and capabilities that are suitable for efficient management. The selection process takes into account experience, expertise in various fields, and alignment with the company's direction and vision. This recruitment process follows a transparent procedure based on good governance principles, aiming to identify personnel with the competence to lead the company toward long-term success and sustainability.


Qualifications of the company's directors and top executives and the recruitment process


The Nomination and Remuneration Committee is responsible for selecting suitable individuals to hold the position of company director and CEO when these positions become vacant, or to replace directors who must vacate their positions due to term expiration. Priority is given to individuals with the skills and experience necessary for the company's and subsidiaries' business operations. The following qualifications will be considered:


  1. Directors must be persons possessing knowledge, competence, integrity, honesty, and business ethics, and must have sufficient time to devote their knowledge, capabilities, and perform duties for the Company.

  2. Directors must possess the qualifications and must not have any prohibited characteristics as prescribed under the law governing public limited companies, the law governing securities and exchange, and other relevant laws. They must also not exhibit any characteristics indicating a lack of appropriateness to be entrusted with the management of a company with public shareholders, as prescribed by the Securities and Exchange Commission (“SEC”).

  3. Directors may hold directorship positions in other companies, provided that such positions do not hinder the performance of their duties as directors of the Company and are in compliance with the guidelines of the SEC and The Stock Exchange of Thailand (“SET”).

  4. Directors must not engage in any business of the same nature and in competition with the Company’s business, nor become a partner in an ordinary partnership, an unlimited liability partner in a limited partnership, or a director of another company conducting business of the same nature and in competition with the Company, whether for their own benefit or for the benefit of others, unless such matter has been disclosed to the shareholders’ meeting prior to the appointment resolution.

  5. Independent directors must possess qualifications relating to independence as prescribed by the Company and in accordance with the criteria announced by the Capital Market Supervisory Board. They must also be capable of safeguarding the interests of all shareholders equally, avoiding conflicts of interest, and attending Board meetings while expressing independent opinions freely.


The Nomination and Remuneration Committee will then select and nominate persons with appropriate qualifications in accordance with the law and specified criteria, taking into account their experience, knowledge, and skills that will be beneficial to the Company, for the Board of Directors to consider. When the Board of Directors has approved the nomination, the Company will propose the said persons for approval to be elected as directors of the Company in the general shareholders' meeting, requesting the resolution of the shareholders' meeting to consider the majority vote of the shareholders attending the meeting. The shareholders' meeting will elect in accordance with the following criteria and methods:


1) Each shareholder has votes equal to the number of shares he holds multiplied by the number of directors to be elected.

2) Each shareholder must use all the votes he has under (1) to elect each director, which must be approved by more than half of the total votes of the shareholders present at the meeting and casting votes.


At every annual general meeting, one-third (1/3) of the directors shall retire from office. If the number of directors cannot be divided exactly into three parts, the number closest to one-third (1/3) shall retire.


In the event that the Company has not appointed a Nomination and Remuneration Committee, or where such Committee does not exist, or is unable to perform its duties due to a lack of quorum or inability to pass resolutions as a result of conflicts of interest, the Board of Directors shall assume the responsibility for nominating and proposing qualified candidates in accordance with the criteria specified in the Charter.

In the case of the appointment of a director to fill a vacancy other than by rotation, or where a director vacates office, the Nomination and Remuneration Committee shall select a candidate who possesses the qualifications as specified in the Charter and does not have any prohibited characteristics under applicable laws, and propose such candidate to the Board of Directors for consideration and appointment as a director. The appointed director shall assume office at the next Board of Directors’ meeting, unless the remaining term of the vacating director is less than two months. A person appointed as a director in such case shall hold office only for the remaining term of the director whom they replace.


Nomination Policy, Criteria, and Process for the Chief Executive Officer

  1. Policy and Qualifications of the Chief Executive Officer

The Nomination and Remuneration Committee is responsible for establishing the policy, criteria, and qualifications for the position of Chief Executive Officer (CEO), ensuring alignment with the size, nature, and complexity of the Company’s hospital business. Key considerations include:

  • Knowledge and experience in the hospital business and healthcare systems, including relevant laws and regulations

  • Capability to manage a multi-branch organization and oversee a large number of medical professionals and support staff

  • Understanding of the diverse needs of service users and the ability to formulate strategies to effectively address such needs

  • Leadership and vision in driving innovation and enhancing the quality of medical services

  • Adherence to integrity, ethics, and principles of good corporate governance, including social responsibility

  • Ability to perform duties free from conflicts of interest, and possession of qualifications in accordance with applicable laws and the Company’s Charter

  1. Nomination Process

When a vacancy arises or upon the nearing completion of a term, the Nomination and Remuneration Committee shall undertake the nomination process by considering candidates from both internal and external sources. The key steps include:

  • Screening candidates whose qualifications and experience align with the hospital business

  • Conducting comprehensive background and qualification checks

  • Evaluating candidates’ knowledge, experience, and specific competencies beneficial to the Company, including the possible use of a Board Skill Matrix designed to assess essential leadership skills for the hospital business, such as medical expertise, finance and accounting, healthcare marketing, and medical risk management, to ensure alignment with the Company’s business direction and development of medical services

  • Proposing qualified candidates to the Board of Directors for consideration and appointment, and/or submitting to the shareholders’ meeting for approval (as applicable)

The Company shall ensure that shareholders are provided with sufficient information regarding nominated candidates to support their decision-making.

  1. Succession Planning

To ensure business continuity and preparedness in the Company’s operations—particularly in the hospital business, which requires specialized expertise—the Nomination and Remuneration Committee shall regularly oversee the development of a succession plan for the Chief Executive Officer and senior executives. Such plan shall include:

  • Identification of potential successors: Selecting and developing high-potential personnel to prepare them for future CEO roles, taking into account individuals with strong knowledge of the hospital business and the Company’s organizational culture

  • Targeted development programs: Establishing development pathways to enhance the knowledge, skills, and experience required for successors, such as training in hospital management, hospital financial management, medical risk management, and leadership development within healthcare service organizations

In addition, the Nomination and Remuneration Committee shall regularly review the CEO nomination criteria and process to ensure that they remain up-to-date, appropriate, and effective.

Are Directors Selected Through the Nomination Committee?

Yes

Are Chief Executives Selected Through the Nomination Committee?

Yes

Directors from Major Shareholders — Introduction

The Company consists of 2 directors appointed by major shareholders, with BBTV Equity Co., Ltd., which is considered a major shareholder of the Company, holding 20.02 percent of the Company's total shares as of December 31, 2025. This shareholding ratio reflects the close business relationship between both parties and its significant role in determining the Company's business direction and strategy, as well as providing advice and suggestions in various areas such as finance, investment, and making decisions on important matters affecting the Company's business operations and sustainability, which can effectively help strengthen and achieve long-term success.

Number of Directors from Major Shareholders

2

Rights of Minority Shareholders on Director Appointment

The selection of suitable individuals to replace directors who have completed their terms will allow minority shareholders to propose candidates who meet the qualifications set out in the Securities and Exchange Act and the company's requirements for consideration as company directors. An invitation will be publicly announced on the company’s website, inviting shareholders to propose names and profiles of candidates. The company has established a minimum shareholding requirement for shareholders who wish to submit nominations in advance. Shareholders must hold at least 3% of the total voting rights of the company, with the shares held until the record date for the right to attend the shareholders' meeting.


To enhance efficiency, accuracy, transparency, and convenience for shareholders in the registration, voting, and vote-counting processes at shareholders’ meetings, the Company has adopted the following practices to ensure that voting results can be accurately processed and promptly announced:

  1. Physical Meeting
    For physical meetings, the Company utilizes a barcode registration system to facilitate the registration process and to support accurate and efficient vote counting.

  2. Electronic Meeting (e-AGM)
    For electronic meetings, the Company adopts an e-Proxy system together with an electronic voting and vote-counting platform through the e-AGM system. This enables shareholders to exercise their voting rights conveniently, transparently, and in a verifiable manner.

In 2025, the Company convened its Annual General Meeting of Shareholders via electronic means (e-AGM) on Monday, 21 April 2025. The Company continued to provide shareholders with the opportunity to vote for the election of directors on an individual basis. The voting and vote-counting processes were conducted in compliance with applicable laws and the Company’s Articles of Association to ensure transparency, accuracy, and auditability.

Method of Director Appointment

Method
Method whereby each director requires approval votes more than half of the votes of attending shareholders with voting rights

Selection of Independent Directors

Introduction

An independent director must maintain independence from major shareholders or groups of major shareholders, as well as from the company's management. They must have sufficient access to the company's financial and business information, as well as insights into other relevant businesses, to provide unbiased opinions in safeguarding the interests of minority shareholders. Independent directors are required to attend Board meetings regularly and are responsible for preparing a declaration of their independence upon appointment. Additionally, they must disclose their independence status in the company's annual report.

Criteria for Selecting Independent Directors

Independent directors must have the qualifications related to independence as specified by the Company and in accordance with the guidelines announced by the Capital Market Supervisory Board. They must be individuals who can equally look after the interests of all shareholders and do not create conflicts of interest. In addition, they must be able to attend the board of directors’ meetings and express their opinions independently. The Company requires that independent directors have the following qualifications:


  1. Holding shares not exceeding 1 percent of the total number of voting shares of the Company, its parent company, subsidiary company, associated company, major shareholder, or controlling person of the Company, including shares held by related persons of such independent director.

  2. Not being or having been a director who participates in the management of the Company, employee, staff, advisor who receives a regular salary, or an authorized person of the Company, its parent company, subsidiary company, associated company, subsidiary company of the same tier, major shareholder, or an authorized person of the Company, unless such qualifications have been removed from the list for at least two years prior to their appointment. Such prohibited qualifications do not include cases where the independent director used to be a civil servant or advisor to a government agency that is a major shareholder or an authorized person of the Company;

  3. Not being a person related by blood or by legal registration as a father, mother, spouse, sibling, and child, including spouse of a child of another director, executive, major shareholder, or authorized person; Or a person to be proposed as a director, executive or controlling person of the Company or its subsidiary.

  4. Does not have or has ever had a business relationship with the Company, its parent company, subsidiary, affiliated company, major shareholder or controlling person of the Company, in a manner that may obstruct the exercise of his/her independent judgment, and is not or has never been a significant shareholder or controlling person of a person with a business relationship with the Company, its parent company, subsidiary, affiliated company, major shareholder or controlling person of the Company, unless he/she has no longer had such characteristics for at least two years prior to appointment.

  5. Does not currently be or has been an auditor of the Company, its parent company, subsidiary, affiliated company, major shareholder or controlling person of the Company, and is not a significant shareholder, controlling person or partner of an audit office which employs auditors of the Company, its parent company, subsidiary, affiliated company, major shareholder or controlling person of the Company, unless he/she has no longer had such characteristics for at least two years prior to appointment.

  6. Not being or having been a professional service provider of any kind, including legal or financial advisory services, who receives a service fee exceeding 2 million baht per year from the Company, its parent company, subsidiary company, associated company, major shareholder or controlling person of the Company, and not being a significant shareholder, controlling person or partner of such professional service provider, unless such status has been relieved for at least two years prior to the appointment.

  7. Not being a director appointed as a representative of the Company’s directors, major shareholders or shareholders who are related to major shareholders.

  8. Not being a person who is engaged in a business of the same nature and in significant competition with the Company’s or subsidiary’s business, or becoming a significant partner in a partnership, or being a director who participates in management, employee, staff member, or consultant who receives regular salary, or holding more than one percent of the total number of voting shares of another company engaged in a business of the same nature and in significant competition with the Company’s or subsidiary’s business.

  9. Not having any other characteristics that prevent him/her from expressing independent opinions on the Company’s operations.


Independent directors shall have a term of office of no more than 9 years from the date of their first appointment as independent directors, unless the Board of Directors considers the necessity and reasonableness of the matter. The Board of Directors must present reasons for the shareholders’ meeting to consider approving the appointment of such person to continue as an independent director of the Company.

Did Any Independent Director Have a Business or Professional Relationship?

No

Director Development

Development of Directors in the Past Year

The Company has a policy to encourage directors to continuously develop their knowledge and skills in their work by encouraging directors to attend training courses or seminars that enhance knowledge and skills related to the Company’s operations. The Board of Directors is committed to continuous self-development by attending seminars, training courses and meetings with the Thai Institute of Directors Association, the Stock Exchange of Thailand, the Securities and Exchange Commission, the Thai Listed Companies Association and other relevant institutions to promote continuous improvement and development of work performance and to apply the knowledge gained to the Company’s operations effectively. In addition, when a new director is appointed, the Company organizes an orientation and prepares a director’s handbook to provide useful information in performing duties, including a presentation on the Company’s business operations so that the new director understands and can effectively hold the position.

Qualifications for Director Selection — Introduction

The company places great importance on the diversity of its Board structure, taking into account the integration of knowledge, expertise, and experience that aligns with the nature and needs of the business. This approach is aimed at enhancing the Board's ability to perform its duties with the highest efficiency, in accordance with the required qualifications and skills framework (Skill Matrix). Such diversity enables decision-making and operations to effectively respond to the company’s strategy. Each director brings expertise in various fields, such as finance, accounting, law, management, business administration, and medicine. These diverse areas of expertise are crucial in strengthening the company’s management and operations, ensuring that the company can achieve its objectives and primary goals efficiently. As a result, the company has established a policy focused on promoting diversity within the Board structure, ensuring balance and the highest level of effectiveness in management.

Qualifications for Director Selection

QualificationSkill & Expertise
Medical134 · Description: Health Care Services
Management1683 · Description: Business Administration
Organizational development134 · Description: Health Care Services · 158 · Description: Corporate Management · 163 · Description: Leadership · 164 · Description: Strategic Management · 1683 · Description: Business Administration
Social145 · Description: Corporate Social Responsibility · 147 · Description: Sustainability · 265 · Description: Governance/ Compliance
Financial112 · Description: Economics · 118 · Description: Banking · 119 · Description: Finance & Securities · 144 · Description: Finance · 149 · Description: Fund Management
Accounting143 · Description: Accounting · 144 · Description: Finance
Legal141 · Description: Law
Engineering157 · Description: Project Management · 159 · Description: Engineering
Information Tecnology140 · Description: Information & Communication Technology · 150 · Description: IT Management · 151 · Description: Data Management

Evaluation of Board & Subcommittee Performance

Criteria for Evaluating Board Performance

Srivichai Vejvivat Public Company Limited (the “Company”) recognizes the importance of effective board governance to ensure that business operations are conducted in accordance with good corporate governance principles, sound self-governance practices, and applicable laws and regulations. Accordingly, the Company has implemented a performance evaluation process for the Board of Directors using evaluation forms developed in alignment with the guidelines of the Stock Exchange of Thailand (SET), and appropriately adapted to suit the Company’s board structure and operational context. The Company requires directors to conduct a self-assessment at least once a year, covering both collective and individual evaluations. The evaluation results serve as an important tool for the Board to collectively review its performance, identify areas for improvement, and enhance the effectiveness and efficiency of the Board’s duties and overall governance practices.

In this regard, the Company conducts Board performance evaluations using assessment forms categorized into three types:

  1. Board of Directors self-assessment (collective assessment)

  2. Board committee self-assessment (collective assessment)

  3. Individual self-assessment of directors and committee members

Self-evaluation of the entire board of directors consists of 6 topics:

  1. Board structure and qualifications;

  2. Roles, duties and responsibilities of the board of directors;

  3. Director self-development and executive development;

  4. Director performance;

  5. Relationship with management; and

  6. Board meetings.


Self-evaluation of the sub-committees as a whole and individual board of directors consists of 3 topics:

  1. Board structure and qualifications ;

  2. Board meetings; and

  3. Roles, duties and responsibilities of directors.


This evaluation form adopts a scoring system to enable assessors to compare results across different evaluation categories and across different years. The meanings of the scores are as follows:

0 = Strongly disagree or no action has been taken in the relevant matter
1 = Disagree or only minimal action has been taken
2 = Agree or moderate action has been taken
3 = Mostly agree or good level of action has been taken
4 = Strongly agree or excellent level of action has been taken

The total score obtained is then calculated as a percentage of the full score and interpreted according to the following criteria:

  • More than 90% = Excellent

  • More than 80% = Very Good

  • More than 70% = Good

  • More than 60% = Fair

  • Below 60% = Needs Improvement

Procedure

The company secretary will send the performance evaluation form to all directors for self-evaluation at the end of each year. After each director has completed the performance evaluation, the performance evaluation form will be returned to the company secretary to compile the evaluation scores and report a summary of the results to the board of directors’ meeting to determine measures to improve the board’s performance.

Evaluation of Board Performance in the Past Year

Board of Directors’ Performance Evaluation for the Year 2025

In 2025, the Company conducted a performance evaluation of the Board of Directors, sub-committees, and individual directors to promote good corporate governance, transparency, and continuous improvement in accordance with governance principles. Overall, the evaluation results reflect that the Board of Directors and its sub-committees performed their duties effectively and transparently, in alignment with good corporate governance practices. The Board continues to play a vital role in setting policies, overseeing risk management, and driving the Company toward sustainable growth.

Summary of the Board of Directors’ Self-Assessment (Board as a Whole) for 2025

The Board self-assessment covered 6 key categories, comprising a total of 59 items.

The overall results were highly satisfactory, with:

  • 56 items rated at Level 4 (Strongly agree / Excellent performance)

  • 3 items rated at Level 3 (Mostly agree / Good performance)

  • This represents an overall score of 98.73%.

Summary of the Self-Assessment of the Board and Sub-Committees (Committee-Level and Individual-Level) for 2025

1. Sub-Committees Self-Assessment (Committee-Level)

The evaluation covered 3 key categories, totaling 36 items.

The overall results were rated at a very good level, with:

  • 31 items rated at Level 4 (Strongly agree / Excellent performance)

  • 5 items rated at Level 3 (Mostly agree / Good performance)

  • This represents an overall score of 96.53%.

2. Individual Self-Assessment of Directors and Sub-Committee Members

The evaluation covered 3 key categories, totaling 11 items.

The overall results were rated at a very good level, with:

  • 11 items rated at Level 4 (Strongly agree / Excellent performance)

  • This represents an overall score of 100%.

Evaluation Results

Evaluated BodyGroup — Carried Out?Group — Grade / Average ScoreGroup — Grade / Full ScoreIndividual (Self-Assessment) — Carried Out?Individual (Self-Assessment) — Grade / Average ScoreIndividual (Self-Assessment) — Grade / Full ScoreCross (Assessing Other Directors) — Carried Out?
Board Of DirectorYExcellentExcellentYExcellentExcellentN
Other SubcommitteeYExcellentExcellentYExcellentExcellentN
Other SubcommitteeYExcellentExcellentYExcellentExcellentN
Audit CommitteeYExcellentExcellentYExcellentExcellentN
Other SubcommitteeYExcellentExcellentYExcellentExcellentN
Other SubcommitteeYExcellentExcellentYExcellentExcellentN

Subcommittees

Subcommittees — Introduction

Other subcommittees have carried out their duties according to the roles and responsibilities assigned with strict adherence, in order to promote Good Governance, Effective Management, and Sustainable Development. They have played a crucial role in overseeing, monitoring, and providing strategic guidance and advice on relevant policies to ensure that the organization's operations are in line with ethical standards, laws, and international standards. The results of their work are as follows:

Subcommittees

Results of the Subcommittee's Duty Performance

In 2025, the Nomination and Remuneration Committee duly performed its duties and responsibilities within the scope assigned to it in a complete and transparent manner, in compliance with good corporate governance principles. The key performances may be summarized as follows:

1. Review of the Structure, Composition, and Qualifications of the Board of Directors
The Committee reviewed the structure and composition of the Board of Directors to ensure appropriateness and alignment with the skills, experience, and expertise required to support the Company’s business operations and long-term sustainable growth.

2. Nomination of Directors in Replacement of Those Retiring by Rotation
The Committee considered the qualifications, knowledge, competencies, and experience of directors retiring by rotation and proposed suitable candidates to the Board of Directors and the shareholders’ meeting for appointment through a transparent and appropriate nomination process.

3. Review and Recommendation of Remuneration Framework for the Board and Sub-Committees
The Committee reviewed and proposed appropriate remuneration structures for directors and sub-committees, ensuring alignment with their duties and responsibilities, the Company’s performance, and industry practices.

4. Consideration and Proposal of Annual Directors’ Remuneration
The Committee considered meeting allowances and overall remuneration packages for submission to the Board of Directors and the shareholders’ meeting for approval, taking into account appropriateness, transparency, and fairness.

5. Oversight of the Nomination and Remuneration Processes in Accordance with Good Governance Principles
The Committee ensured that nomination and remuneration determination processes were conducted transparently, were verifiable, and complied with the Company’s corporate governance policies.

6. Reporting to the Board of Directors
The Committee regularly reported its considerations and recommendations to the Board of Directors to support effective corporate oversight and decision-making at the organizational level.


The Nomination and Remuneration Committee performed its duties with caution, thoroughness, and transparency, providing candid and independent opinions. Directors with a conflict of interest did not participate in meetings or voting to ensure that the recruitment and remuneration processes were transparent and in the best interest of the company, shareholders, investors, and all stakeholders.


In 2025, the Corporate Governance Committee carried out its duties to monitor and oversee operations as assigned, and reported the outcomes of its meetings to the Board of Directors. The key points can be summarized as follows:


1. Oversight and Promotion of Sustainability Operations
Reviewed and approved the Company’s sustainability operational plans under the ESG framework, encompassing environmental, social, governance, and economic dimensions, including human rights considerations and climate change management approaches. The Committee also provided recommendations to enhance operational practices to ensure effective implementation and practical application across the organization.

2. Promotion of Good Corporate Governance and Anti-Corruption Practices
Reviewed the Company’s anti-corruption policy and supported employee training programs aimed at strengthening awareness and understanding of anti-corruption practices, including post-training assessments to ensure effective knowledge transfer and compliance with the Company’s standards.

3. Expansion of Business Transparency Collaboration Network
Encouraged and supported initiatives to invite customers, business partners, and stakeholders to join the Company’s anti-corruption network, thereby strengthening transparency standards throughout the value chain.

4. Monitoring ESG Trends and Future Assessment Frameworks
Exchanged views and monitored developments regarding emerging sustainability assessment frameworks, such as FTSE Russell ESG Scores, in order to prepare the Company for future changes in ESG evaluation criteria and expectations.

5. Review and Promotion of Compliance with Good Corporate Governance Policies
Continuously reviewed the Company’s corporate governance policies to enhance transparency and accountability, while promoting effective and practical implementation of governance practices throughout the organization.


The Corporate Governance and Sustainability Committee reaffirmed its dedication to conducting business under good corporate governance principles, business ethics, and anti-corruption measures. These elements are key in enhancing transparency and fairness in all processes, building trust among shareholders and stakeholders, and ensuring the company’s long-term sustainable growth.


In 2025, the Financial Planning and Investment Working Group carried out its responsibilities as assigned by the Board of Directors efficiently and effectively. The group held two meetings to review and act on the following matters:


1. Consideration of Investment Projects and Investment Plans
The Working Committee carefully reviewed investment projects, investment plans, and capital expenditure budgets of the Company and its subsidiaries by assessing project feasibility, expected financial returns, and associated risk factors to ensure alignment with the Company’s objectives, strategies, and operational plans. Such considerations were undertaken with due regard to the Company’s long-term benefits and sustainable growth.

2. Consideration of Significant Financial Transactions and Funding Arrangements
The Working Committee reviewed and endorsed significant financial transactions, including appropriate funding arrangements to support the Company’s business operations, prior to submission to the Board of Directors for approval in accordance with good corporate governance practices.

3. Monitoring and Evaluation of the Company’s Investments
The Working Committee continuously monitored, reviewed, and evaluated investments undertaken by the Company and its subsidiaries in a transparent manner while ensuring the prevention of conflicts of interest. The objective was to secure returns in line with established targets, with regular progress updates and performance reports on approved investment projects submitted to the Board of Directors.

4. Monitoring and Evaluation of Performance in Line with Corporate Strategy
The Working Committee monitored and evaluated business performance in alignment with corporate strategy by reviewing the potential of existing businesses, operational constraints, business diversification, and expansion opportunities to ensure consistency with the direction, objectives, and policies established by the Board of Directors.

5. Provision of Strategic Advice to Management
The Working Committee provided strategic advice and recommendations to management in identifying suitable business opportunities and operational approaches aimed at supporting future growth and strengthening the Company’s competitive capabilities.

6. Performance of Other Duties as Assigned
The Working Committee also performed other duties as assigned by the Board of Directors with due diligence and efficiency to support the Company’s operations in achieving its strategic objectives and business plans.


The Financial Planning and Investment Working Group performed its duties with caution and thoroughness, providing independent opinions while prioritizing the company’s overall interests. They closely monitored and evaluated investment projects to ensure that the company met its target returns. Additionally, the group worked to prevent and mitigate any risks that may arise from project execution. The investment decisions made by the company were carefully studied and analyzed both broadly and deeply by internal and external experts, following corporate governance principles to foster the company's sustainable and stable growth in the future.


In 2025, the Risk Management Committee convened a total of two meetings to oversee, supervise, and monitor the Company’s risk management processes to ensure they were systematically implemented and aligned with the Company’s strategic direction. The key outcomes of its performance are summarized as follows:

  • Review of the Structure and Composition of the Risk Management Committee

The Committee reviewed the composition and appropriateness of the Risk Management Committee to ensure that its members collectively possess sufficient knowledge, expertise, and experience to effectively oversee the Company’s enterprise risk management. This includes the capability to identify events or risk factors that may impact the Company’s business operations and to establish appropriate risk management measures to maintain risks within the Company’s acceptable risk appetite. Such efforts aim to provide reasonable assurance that the Company can achieve its strategic objectives and business goals.

  • Review of Roles, Responsibilities, and Enterprise Risk Management Policy

The Committee reviewed the Company’s enterprise risk management policy and framework for 2025 to ensure comprehensive coverage of five principal risk categories, namely Strategic Risk, Operational Risk, Financial Risk, Compliance Risk, and Emerging Risk. Particular attention was given to pricing competition risks in the Mobile Medical Unit (MMU) health screening services business, as well as potential risks arising from changes in reimbursement conditions within the life insurance business, which may impact the Company’s operating performance and long-term competitiveness.


The Risk Management Committee carried out its responsibilities in a thorough and effective manner, continuously reviewing and overseeing risk management activities across various domains. This ensured that the operations of the company and its subsidiaries adhered to established standards while minimizing risks that could potentially affect business operations and the organization's reputation in the long term.


In 2025, The CEO Performance Evaluation Sub-Committee duly performed its duties and responsibilities within the scope of authority assigned to it. During the year, the Sub-Committee convened one meeting to evaluate the performance of the Chief Executive Officer, with the objective of reviewing the overall operating results of the Company as well as the CEO’s capability in driving the organization to achieve its strategic goals and business direction.

The evaluation was conducted systematically in accordance with established criteria and procedures, covering key areas including financial performance, business growth, organizational management efficiency, risk management, implementation of strategic plans and key corporate initiatives, as well as leadership capabilities, executive and personnel development, and organizational strengthening to support long-term sustainable growth.

The evaluation results were subsequently summarized and submitted to the Chairman of the Board of Directors for consideration in determining the Chief Executive Officer’s remuneration. The Sub-Committee carried out the evaluation process with due care, transparency, and fairness to ensure that remuneration determination appropriately reflects performance outcomes and responsibilities undertaken.

In addition, the Sub-Committee provided recommendations aimed at enhancing management effectiveness and operational efficiency on a continuous basis, thereby supporting the Company’s competitiveness and long-term sustainable development.

The Sub-Committee’s performance reflects the Company’s commitment to maintaining high standards in the evaluation of senior executive performance, strengthening confidence in the Company’s governance processes, and ensuring that remuneration determination is transparent, appropriate, and genuinely aligned with organizational performance.


Meeting Attendance & Remuneration

Meeting Attendance & Remuneration — Introduction

The Company established an annual schedule for meetings of the Board of Directors in advance, with meetings held on a monthly basis throughout the year. This approach enables all directors to be informed of the meeting schedule ahead of time and to appropriately allocate their time to attend meetings on a regular and continuous basis.

For each meeting, the meeting agenda is clearly determined in advance and includes follow-up agenda items to report on and monitor the progress of matters previously assigned or resolved by the Board of Directors. The Company Secretary circulates the notice of meeting, together with the meeting agenda and supporting documents, to all directors at least five (5) business days in advance, allowing sufficient time for directors to review and consider the information prior to the meetings. This practice supports effective oversight, transparency, and informed decision-making in accordance with good corporate governance principles.

In 2025, the Company held a total of twelve (12) meetings of the Board of Directors and one (1) Annual General Meeting of Shareholders.

Justification for Directors' Non-Attendance

1. Personal commitments or emergencies that cannot be avoided, or unforeseen events that prevent attendance, such as sudden illness or travel that cannot be postponed or canceled.

2. Conflicts with other obligations or schedules, such as overlapping meetings or tasks that coincide with the Board meeting, for instance, a meeting in another organization that is of equal or higher priority.

3. Health issues, such as illness that prevents participation in the meeting or the need to undergo medical treatment.

4. International travel: Directors may have commitments involving overseas travel, which may prevent them from attending the scheduled meeting.

Types of Remuneration of the Board of Directors

The company provides compensation to the Board of Directors in various forms, including meeting allowances for each meeting and a monthly remuneration, which is paid only to directors who are not executives. For other forms of compensation, after deducting the meeting allowances and monthly remuneration, the Chairman of the Board has the authority to consider and implement the payment of additional compensation as deemed appropriate. Overall, the total compensation shall not exceed the allocated amount, which is capped at 8,000,000 Baht.


Additionally, the company provides non-monetary benefits in the form of healthcare benefits and tailored suits for the Board of Directors as a means of supporting and taking care of the directors' well-being in areas related to the performance of their duties.

Remuneration of the Board — Introduction

In 2025, the company and its subsidiaries paid compensation in the form of meeting allowances and salaries to each director as follows:

Remuneration or Benefits Payable to the Board

MetricAmount (Baht)
Remunerations or benefits pending payment to the board of directors over the past year (baht)0

Supervision of Subsidiaries & Associated Companies

Supervision of Subsidiaries — Introduction

The company has established a governance policy for its subsidiaries and affiliated companies, with the objective of ensuring that the company can effectively oversee and monitor its subsidiaries and affiliates to comply with various measures and mechanisms as specified. This is to ensure adherence to the company's policies, as well as relevant laws including the Public Limited Companies Act, the Civil and Commercial Code, the Securities Act, and other related laws, as well as the announcements, regulations, and guidelines from the Securities and Exchange Commission, the Securities and Exchange Commission Office, and the Stock Exchange of Thailand. This is to safeguard the company’s investment interests in its subsidiaries and affiliates, with the following details:

  1. The Company shall appoint representatives to serve as directors and/or executives of each subsidiary or associate to oversee its operations in accordance with the Company’s policies, objectives, vision and strategic plans. The Company shall also establish measures to monitor the management of subsidiaries and associates to safeguard its investment interests. The appointment of representatives as directors and/or executives of each subsidiary or associate shall be considered and approved by the Company’s Board of Directors, taking into account the circumstances of each entity.

  2. Directors and executives of subsidiaries shall disclose and submit information on their own interests and those of related persons in connection with transactions in other businesses that may reasonably be expected to give rise to conflicts of interest with the Company or its subsidiaries. Such information shall be submitted to the subsidiary’s board of directors or its designated person within the period prescribed by the subsidiary. Directors and executives of subsidiaries shall not participate in approving matters in which they have an interest or a conflict of interest.

  3. Matters requiring the approval or endorsement of the Company’s Board of Directors or shareholders’ meeting before a subsidiary or associate proceeds

    3.1 Approval of annual and interim dividends, if any, of a subsidiary.

    3.2 Increases or reductions in a subsidiary’s capital and allocations that are not proportionate to existing shareholdings and may result in the Company losing control of the subsidiary.

    3.3 Transactions or actions by a subsidiary that constitute an acquisition or disposal of assets under the relevant notifications on the acquisition or disposal of assets, or connected transactions under the relevant notifications on connected transactions.

    3.4 Amendments to a subsidiary’s objectives and Articles of Association.

    3.5 Approval of a subsidiary’s strategic plan and annual budget.

    3.6 Appointment of a subsidiary’s auditor.

    3.7 Transfer, sale or dissolution of a subsidiary or associate.

    3.8 Purchase or acquisition by transfer of another company’s business to become a subsidiary.

    3.9 Changes in the shareholding proportions in a subsidiary or associate.

    3.10 Leasing, or letting under hire-purchase arrangements, all or a material part of a subsidiary’s business or assets. 3.11 Borrowing, lending, granting credit, providing guarantees or entering into juristic acts binding a subsidiary outside the ordinary course of business that increase its financial obligations, except for short-term borrowings or working capital financing, or long-term borrowings under strategic plans or annual budgets already approved by the Company’s Board of Directors.

    3.12 Any other transaction outside the ordinary course of a subsidiary’s business that materially affects the subsidiary.

  4. Subsidiaries shall submit operational information or documents to the Company upon request, as appropriate.

  5. Where the Company identifies any material issue, it may request the subsidiary to provide clarification and/or supporting documents for the Company’s consideration.

  6. Directors, executives or related persons of a subsidiary may enter into transactions with that subsidiary only after the transactions have been approved by the Company’s Board of Directors or shareholders’ meeting, as applicable, based on the transaction size calculated in accordance with the criteria prescribed in the notifications on connected transactions. An exception applies to transactions on commercial terms that a reasonable person would agree with an ordinary counterparty in comparable circumstances, with bargaining power free from the influence of the person’s status as a director, executive or related person, as applicable, provided that those commercial terms have been approved by the Company’s Board of Directors or comply with principles previously approved by the Board.


In 2025, the company has 5 subsidiaries, namely: Saivichai Development Co., Ltd., Srisakorn Vejavivat Co., Ltd., Bangkok Orthopedic Hospital Co., Ltd., Srivichai Vocational School Co., Ltd., and Watthana Vejvivat Co., Ltd. Individuals appointed as directors of these subsidiaries are responsible for acting in the best interests of the respective subsidiaries. The company has specified that such appointments must be approved by the Board of Directors before they can cast votes or exercise voting rights on important matters. In the case of subsidiaries, individuals appointed by the company must ensure that the subsidiary has regulations on related party transactions that are aligned with the company’s policies. They must also ensure proper recordkeeping and accounting practices so that the company can conduct audits and consolidate the financial statements in a timely manner. All directors, executives, and employees of both the company and its subsidiaries must be aware of and adhere to the important policies, including the company’s code of conduct and other procedures related to corporate governance principles, ensuring consistency across the organization.


Further details are available in the full version of the policy, which is published on the Company’s website at the following link: https://shorturl.asia/htikjx

Does the Company Have Subsidiaries or Associated Companies?

Yes

Is There a Mechanism for Overseeing Subsidiaries and Associated Companies?

Yes

Mechanism for Overseeing Management of Subsidiaries

Srivichai Vejvivat Public Company Limited emphasizes on the effective supervision of subsidiaries and associated companies to ensure that the operations of the affiliated companies are in accordance with the policies, strategies and management standards set by the Company, as well as in accordance with relevant laws and regulations. The main practices for supervision are as follows:


  1. Subsidiary and Associated Company Governance Structure

The Company appoints the Subsidiary and Associated Company Committee to supervise the operations in accordance with the Company’s guidelines. The roles, duties and management authority are clearly defined to ensure that the operations of subsidiaries and associated companies are in accordance with the Group’s policies. The performance of subsidiaries and associated companies is closely monitored through monthly performance reports.


  1. Policy and Operational Guidelines

The subsidiaries and associated companies are required to comply with the parent company’s main policies, such as the Corporate Governance Policy, Risk Management Policy and Code of Conduct Policy. The operational guidelines for management, investment, risk management and compliance with the law are defined to ensure that subsidiaries and associated companies operate efficiently and transparently.


  1. Internal Control and Risk Management

There is an internal audit system covering subsidiaries and associated companies to prevent financial and operational risks. There are measures to prevent and manage corruption risks and conflicts of interest to ensure that the operations of subsidiaries and associated companies are in accordance with the principles of good governance. The Audit Committee plays a role in monitoring, reviewing and evaluating the performance of subsidiaries and associates continuously.

  1. Supervision of information disclosure

The subsidiaries and associates are required to have transparent information and data disclosure guidelines and comply with the criteria of the regulatory agency. The performance and important information are reported to the Board of Directors and shareholders. Intercompany transactions, other transactions and transactions between affiliated companies are supervised in accordance with the principles of good governance and the disclosure of related information is complete.


  1. Role of the Board of Directors in Supervising Subsidiaries and Associates

  • The Board of Directors is responsible for supervising the policies and practices of subsidiaries and associates to ensure that they are in line with the goals of the Group.

  • The Executive Committee plays a role in determining the strategies and operational plans of subsidiaries and associates, including monitoring the performance to achieve the goals.

  • The Audit Committee is responsible for monitoring and following up on the internal control system, risk management and financial transparency of subsidiaries and associates.

  1. Management of Shareholders’ Benefits

The Company places importance on the rights and benefits of shareholders, taking into account fairness and appropriate returns. There are measures to prevent conflicts of interest and requires that related transactions be carefully considered. Information about subsidiaries and associates is disclosed transparently so that shareholders receive correct and sufficient information.


The governance mechanism of Srivichai Vejvivat Public Company Limited's subsidiaries and associates has been designed to be in line with good corporate governance standards, with a clear management structure, a strong internal control system and strict risk management measures to ensure that the operations of subsidiaries and associates are in line with the investment policies and governance of the subsidiaries and associates and can create sustainable value for shareholders and stakeholders.

Oversight Mechanisms

Mechanism
Sending representatives to act as directors, executives or controlling persons in proportion to shareholdings
Defining the scope of powers, duties and responsibilities of directors and executives who represent the company in setting important policies
Disclosure of financial information and operating results
Transactions between the Company and related persons
Other important transactions
Acquisition or disposal of assets
Internal control system of the subsidiary operating the core business is appropriate and sufficient in the subsidiary operating the core business

Agreements Between the Company and Shareholders in Managing Subsidiaries

Srivichai Vejvivat Public Company Limited has no shareholders’ agreements of material significance that affect the management or control of its subsidiaries and associated companies, other than those stipulated under applicable laws and the articles of association. The Company manages its subsidiaries and associated companies in accordance with the principles of good corporate governance, transparency, and due regard for the rights of shareholders and other stakeholders.

Board Duty Performance — Overview

Board Duty Performance — Overall Description

In 2025, the Board of Directors has effectively fulfilled its roles and responsibilities in accordance with the principles of Good Corporate Governance (CG) to promote transparency, enhance operational efficiency, and create value for shareholders and all stakeholders.

Audit Committee Duty Performance

Results of the Audit Committee's Duty Performance in the Past Year

In 2025, the Audit Committee performed its duties independently, transparently, and with due diligence in accordance with the responsibilities assigned by the Board of Directors. The Committee aimed to support the Company in maintaining good corporate governance, effective risk management, and appropriate internal control systems to ensure that business operations are conducted efficiently, transparently, and in a verifiable manner.

The Audit Committee placed importance on reviewing the accuracy and reliability of financial reports and ensuring that material information disclosures comply with applicable standards and requirements. The Committee also monitored the adequacy and effectiveness of the Company’s internal control and internal audit systems, as well as overseeing the enterprise risk management process to ensure alignment with the Company’s business direction and the evolving operating environment.

In addition, the Committee considered the independence of the external auditor, monitored compliance with applicable laws and regulations, and reviewed transactions that may give rise to conflicts of interest to ensure fairness and to safeguard the interests of shareholders and all stakeholders.

Overall, the Audit Committee is of the opinion that the Company maintains adequate internal control systems, risk management processes, and governance practices that support transparent, efficient, and sustainable business operations.

However, In performing its duties for the year 2025, the Audit Committee has performed its duties diligently and independently, and has had unrestricted access to the Company's information. All Audit Committee members attended every meeting and discussed relevant matters with internal auditors and external auditors. The summary of the performance of duties is provided in the Audit Committee Report, Attachment 6.

Executive Committee Duty Performance

Results of the Executive Committee's Duty Performance in the Past Year

During the year 2025, the Executive Committee duly performed its duties and responsibilities as delegated by the Board of Directors in a comprehensive, prudent, and continuous manner. The Executive Committee played a key role in overseeing, monitoring, and supporting the management’s operations to ensure that the Company’s business operations were conducted in accordance with its strategies, policies, and objectives, under the principles of good corporate governance, transparency, and accountability to stakeholders. The summary of the Executive Committee’s performance is as follows:

1. Oversight and Monitoring of Operating Performance

The Executive Committee regularly monitored and reviewed the operating performance of the Company and its subsidiaries, including revenues, expenses, financial results, and operational efficiency of each business unit. Performance was assessed against the established targets and plans, enabling the Committee to provide timely recommendations and guidance to improve and enhance operational efficiency.

2. Review of Strategies, Plans, and Key Projects

The Executive Committee reviewed and provided opinions on the strategic plans, business plans, and key projects of the hospital group, both in the short and long term, to ensure alignment with the business environment, competitive landscape, and trends in the healthcare industry. This included the development and enhancement of medical services, expansion of specialized services, investment in new projects, oversight of new medical products and services, and the integration of operations among hospitals within the group to strengthen competitiveness and support sustainable growth. The Committee’s views were presented to the Board of Directors to support policy-level decision-making.

3. Risk Management and Internal Control

The Executive Committee emphasized enterprise risk management by considering significant risks across financial, operational, information technology, personal data protection, and regulatory compliance aspects. The Committee also monitored the effectiveness of internal control systems to ensure that the Company’s operations were conducted prudently and transparently, while mitigating risks that could materially impact the organization in the long term.

4. Legal, Regulatory, and Corporate Governance Oversight

The Executive Committee ensured that the Company’s business operations complied with applicable laws, regulations, and requirements of relevant regulatory authorities, as well as the principles of good corporate governance. Particular emphasis was placed on transparency, accountability, ethical business conduct, and the protection of the rights and interests of shareholders and other stakeholders.

5. Human Resource Management and Organizational Development

The Executive Committee reviewed and provided recommendations on human resource management matters, including policies for employee development and capacity building to strengthen organizational capabilities and management continuity. Consideration was given to organizational structure, incentive systems, and appropriate employee welfare to attract, retain, and develop competent personnel, promote high-quality human capital, and enhance organizational efficiency. The Committee also supported the promotion of an organizational culture grounded in ethics, transparency, and responsibility.

6. Enhancement of Service Quality and Customer Satisfaction

The Executive Committee placed strong emphasis on the quality of medical services, patient safety, and the continuous improvement of service standards. The Committee monitored complaints, feedback, and improvement initiatives to enhance service quality, build trust, and strengthen satisfaction among service recipients and stakeholders.

7. Technology, Innovation, and System Development

The Executive Committee reviewed and guided the adoption of technology and innovation in medical services and management processes. The Committee supported the development of digital systems and information technology infrastructure to enhance operational efficiency, data security, and the overall experience of service recipients.

8. Sustainability and ESG Integration

The Executive Committee reviewed and supported the Company’s sustainability initiatives by integrating environmental, social, and governance (ESG) considerations into business operations. Key areas included stakeholder engagement, human capital development, personal data protection, and responsible business practices, aimed at creating long-term value and sustainable growth in alignment with international practices and the FTSE Russell assessment framework.

9. Support for the Board of Directors’ Decision-Making

The Executive Committee consistently prepared and submitted reports, deliberations, opinions, and recommendations to the Board of Directors to support prudent, appropriate, and well-informed policy-level decision-making, aligned with the Company’s long-term sustainable growth strategy.

Contents